ID

14502

Descripción

Effects of Montelukast in Children With Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00675285

Link

https://clinicaltrials.gov/show/NCT00675285

Palabras clave

Versiones (1)
  1. 19/4/16 19/4/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

19 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Asthma NCT00675285

Inglés

Eligibility Asthma NCT00675285

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00675285
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
children 6 to 14 yrs old, step 1 and step 2 gina (global initiative for asthma) guidelines
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
exhaled nitric oxide (no) >20 ppb at visit 2
Descripción

exhaled nitric oxide

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3700245
symptoms more often than twice a day, fev1 equal or higher than 80% of predicted value and reversibility equal or higher than 12% to salbutamol, or a positive provocation test with methacholine, or exercise
Descripción

symptom frequency, fev1, methacholine challenge, exercise

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0436350
UMLS CUI [1,2]
C0004096
UMLS CUI [2]
C0748133
UMLS CUI [3,1]
C0748133
UMLS CUI [3,2]
C0449261
UMLS CUI [3,3]
C0001927
UMLS CUI [4]
C0430567
UMLS CUI [5]
C0015259
no regular medication, inhaled short-acting beta-2 agonists for symptom relief
Descripción

asthma medication

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0004096
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient is hospitalized
Descripción

inpatient

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021562
patient has fev1 < 80% predicted on visit 1
Descripción

fev1

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0748133
patient has 2 or more nighttime awakenings for asthma per week or pef variability 30% or more
Descripción

asthma nighttime symptoms or pef variability

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1273489
UMLS CUI [1,2]
C0860510
UMLS CUI [2,1]
C0030735
UMLS CUI [2,2]
C2827666
upper respiratory infection in the previous 3 weeks
Descripción

upper respiratory infection

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0041912
UMLS CUI [1,2]
C0040223
treatment with glucocorticoids or ltras in the previous 4 weeks
Descripción

glucocorticoids or ltras

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0017710
UMLS CUI [2]
C0595726
treatment with inhaled glucocorticoids for more than 4 weeks in the previous year
Descripción

inhaled steroids

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2065041
UMLS CUI [1,2]
C0040223
Volver a la parte superior de la página

Similar models

Eligibility Asthma NCT00675285

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00675285
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
children 6 to 14 yrs old, step 1 and step 2 gina (global initiative for asthma) guidelines
boolean
C0001779 (UMLS CUI [1])
exhaled nitric oxide
Item
exhaled nitric oxide (no) >20 ppb at visit 2
boolean
C3700245 (UMLS CUI [1])
symptom frequency, fev1, methacholine challenge, exercise
Item
symptoms more often than twice a day, fev1 equal or higher than 80% of predicted value and reversibility equal or higher than 12% to salbutamol, or a positive provocation test with methacholine, or exercise
boolean
C0436350 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0748133 (UMLS CUI [2])
C0748133 (UMLS CUI [3,1])
C0449261 (UMLS CUI [3,2])
C0001927 (UMLS CUI [3,3])
C0430567 (UMLS CUI [4])
C0015259 (UMLS CUI [5])
asthma medication
Item
no regular medication, inhaled short-acting beta-2 agonists for symptom relief
boolean
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
inpatient
Item
patient is hospitalized
boolean
C0021562 (UMLS CUI [1])
fev1
Item
patient has fev1 < 80% predicted on visit 1
boolean
C0748133 (UMLS CUI [1])
asthma nighttime symptoms or pef variability
Item
patient has 2 or more nighttime awakenings for asthma per week or pef variability 30% or more
boolean
C1273489 (UMLS CUI [1,1])
C0860510 (UMLS CUI [1,2])
C0030735 (UMLS CUI [2,1])
C2827666 (UMLS CUI [2,2])
upper respiratory infection
Item
upper respiratory infection in the previous 3 weeks
boolean
C0041912 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
glucocorticoids or ltras
Item
treatment with glucocorticoids or ltras in the previous 4 weeks
boolean
C0017710 (UMLS CUI [1])
C0595726 (UMLS CUI [2])
inhaled steroids
Item
treatment with inhaled glucocorticoids for more than 4 weeks in the previous year
boolean
C2065041 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial